Zoetis Inc. (NYSE:ZTS) Holdings Lifted by Westwood Holdings Group Inc.

Westwood Holdings Group Inc. grew its position in Zoetis Inc. (NYSE:ZTS) by 4.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 171,274 shares of the company’s stock after purchasing an additional 7,309 shares during the period. Westwood Holdings Group Inc.’s holdings in Zoetis were worth $29,692,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of ZTS. Price T Rowe Associates Inc. MD grew its position in Zoetis by 31.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock worth $2,707,262,000 after purchasing an additional 3,244,074 shares during the last quarter. Sarasin & Partners LLP grew its position in Zoetis by 546.3% in the 2nd quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock worth $390,682,000 after purchasing an additional 1,904,899 shares during the last quarter. Swedbank AB bought a new position in Zoetis in the 1st quarter worth about $210,815,000. Public Employees Retirement Association of Colorado acquired a new stake in shares of Zoetis in the 4th quarter worth approximately $242,757,000. Finally, CIBC Private Wealth Group LLC lifted its stake in shares of Zoetis by 122.6% in the 4th quarter. CIBC Private Wealth Group LLC now owns 1,448,665 shares of the company’s stock worth $285,923,000 after acquiring an additional 797,884 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the subject of a number of research analyst reports. Piper Sandler upped their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. BTIG Research upped their price target on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Argus raised shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Finally, Stifel Nicolaus increased their target price on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday. Nine investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Zoetis presently has an average rating of “Buy” and an average price target of $220.38.

Zoetis Stock Down 0.3 %

Shares of NYSE:ZTS opened at $192.64 on Friday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The company has a market cap of $87.90 billion, a PE ratio of 37.12, a price-to-earnings-growth ratio of 2.98 and a beta of 0.88. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The firm has a 50 day simple moving average of $184.70 and a 200 day simple moving average of $174.40.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. The business had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The firm’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.41 EPS. As a group, research analysts expect that Zoetis Inc. will post 5.84 earnings per share for the current year.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.